Elderly Patient at Risk of Loss of Mobility, Exercise - Primary Care, Prevention, Care Pathways (PRISME-3P)

December 13, 2025 updated by: Hospices Civils de Lyon

Prevention of Loss of Mobility From a Care Pathway Focused on Exercise and Nutrition in Elderly Patients Over 70 Years, in Primary Care. Cluster Randomized Controlled Trial

Loss of mobility is predictive of a loss of autonomy and is often the first sign of functional decline. Loss of mobility is also associated with poor perceived quality of life, depressive symptoms, high risk of adverse events such as falls and fractures, to an increased risk to input in institution and mortality's increase.

Consequences and frequency of loss of mobility make essential its identification, evaluation and the practice of preventive measures in primary care.

The implementation of effective interventions in primary care to prevent or delay the loss of mobility is a public health priority.

PRISME-3P program aims to develop and evaluate a dedicated care pathway, in primary care, based on a personalized multimodal intervention: screening, support combining physician, teaching exercises by a specialized Monitor in Adapted Physical Activities (MAPA) and nutritional counseling.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pierre-Bénite, France, 69310
        • Service de Médecine Gériatrique. Groupement Hospitalier Sud. Hospices Civils de Lyon.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged > 70 years
  • With at least 2 of the following signs:

    1. Difficulty in carrying a shopping bag (load about 4.5 Kg)
    2. Difficulty in getting up from a chair without using arms
    3. Difficulty in climbing 10 stairs
    4. Difficulty in moving, walking slow
    5. Difficulty in walking more than 400 meters without stop
    6. Running time <1 hour / week
    7. Fatigue at modest physical effort: shopping, housework ...
    8. At least two falls in the last year
    9. Weight loss ≥5% in 1 month or weight loss ≥10% in 6 months
  • Short Physical Performance Battery score < 10

Exclusion Criteria:

  • Locomotor disability not allowing implementation of the protocol according to the investigator
  • Life expectancy less than 6 months
  • Severe chronic progressive pathologies incompatible with the completion of the physical activity program
  • Patient institutionalized in nursing homes
  • Advanced Cognitive impairment (MMSE <20)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Multimodal Intervention
The multimodal intervention on mobility will consist of the implementation of a care pathway dedicated in primary care. It will include awareness and training of general practitioners for easy identification, a care associating a dedicated geriatric consultation to rule out underlying pathology, teaching exercises by MAPA (+/- taken care in the presence of MAPA) and nutritional counseling by a dietician. Close collaboration between general practitioners, geriatrician, MAPA and dietician will be established.

PRISM-3P program will consist on a visit in the geriatric centre:

  • Consultation with the geriatrician to rule a condition associated with loss of mobility and not known until now.
  • Perform a nutritional assessment by a dietician followed by appropriate care management.
  • Educational activity based on exercises and physical activity and balance: MAPA teaches exercises to develop strength and balance; gives tips to increase time spent on non-sedentary activities and enhance endurance followed by a monthly phone coaching.
  • At 3 months, in case of no improvement of the SPPB score of 1 point, a training of 10 weeks with two sessions per week will be perform by the MAPA individually or in small patients groups;
  • Implementation of a information exchange processing (mail, phone and book binding) between the various stakeholders.
No Intervention: Non interventional
Patients received treatment as part of their standard care: at the discretion of the general practitioner patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Short Physical Performance Battery (SPPB) score
Time Frame: from baseline at 6 months
Consists in estimating three components: 1. walking, 2. muscular strength and endurance, and 3. balance through short physical exercises (walk on a defined distance, get up from a chair, keep a position up). A score from 1 to 3 for each of the components marks a very low feature of lower limbs. This feature is considered low of 4 in 6, moderated by 7 in 9 and high of 10 in 12.
from baseline at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of the Short Physical Performance Battery (SPPB) score
Time Frame: Baseline, 3 months (for interventional arm), 6 months and 12 months
Consists in estimating three components: 1.walking, 2.muscular strength and endurance, and 3. balance through short physical exercises (walk on a defined distance, get up from a chair, keep a position up). A score from 1 to 3 for each of the components marks a very low feature of lower limbs. This feature is considered low of 4 in 6, moderated by 7 in 9 and high of 10 in 12.
Baseline, 3 months (for interventional arm), 6 months and 12 months
Assessment of functional disability by questionnaires
Time Frame: Baseline, 6 months and 12 months
Functional disability refers to limitations in performing in dependent living tasks, which are often further divided into activities of daily living (ADLs), which include basic activities of hygiene and personal care, and instrumental activities of daily living (IADLs), which include basic activities necessary to reside in the community, such as shopping, managing finances, housekeeping, and meal preparation
Baseline, 6 months and 12 months
Assessment of Quality of Life by questionnaire
Time Frame: baseline, 6 months and 12 months
The Quality of Life is assessed with the 12-Item Short Form Health Survey (SF-12). The SF-12 is a multipurpose short form survey with 12 questions which were combined, scored, and weighted to create two scales that provide glimpses into mental and physical functioning and overall health-related-quality of life
baseline, 6 months and 12 months
Number of falls
Time Frame: Baseline, 6 months and 12 months
Data will be collected by the geriatrician from the patient's medical records
Baseline, 6 months and 12 months
Number of hospitalization
Time Frame: Baseline, 6 months and 12 months
Data will be collected by the geriatrician from the patient's medical records
Baseline, 6 months and 12 months
Assessment of the Physical Activity by questionnaire
Time Frame: baseline, 6 months and 12 months
Using the Physical Activity Scale for the Elderly (PASE) auto-questionnaire which is designed to assess the duration, frequency, exertion level, and amount of physical activity undertaken over a seven day period.
baseline, 6 months and 12 months
Assessment of sedentary time by questionnaire
Time Frame: baseline, 6 months and 12 months
Using self-report sedentary behavior questionnaire based on the Gardiner questionnaire to assess time spent in behaviors common among older adults: watching television, computer use, reading, socializing, transport and hobbies, and a summary measure (total sedentary time)
baseline, 6 months and 12 months
Assessment of weight loss
Time Frame: baseline, 6 months and 12 months
weight in kilograms
baseline, 6 months and 12 months
Body Mass Index (BMI)
Time Frame: baseline, 6 months and 12 months
calculating the BMI in kg/m^2
baseline, 6 months and 12 months
Assessment of nutritional status using MNA scale
Time Frame: baseline, 3 months (for interventional arm depending on the SPPB score), 6 months and 12 months
Using the Mini Nutritional Assessment (MNA) scale which consists of 18 point-weighted questions in four categories, i.e., anthropometry, global and dietary issues, and self-assessment.
baseline, 3 months (for interventional arm depending on the SPPB score), 6 months and 12 months
Rate of study participation
Time Frame: Baseline
Baseline
Monitoring of detailed physical activity performed by patients with diaries outlining the exercise sessions .
Time Frame: at the end of the multimodal intervention (3 months)
Patient adherence to the multimodal intervention. Monitoring of detailed physical activity performed by patients. Patients were also asked to complete diaries outlining the exercise sessions.
at the end of the multimodal intervention (3 months)
Monitoring of detailed physical activity performed by patients with MAPA assessment.
Time Frame: at the end of the multimodal intervention (3 months)
Patient adherence to the multimodal intervention. Monitoring of detailed physical activity performed by patients. Patients MAPA assessment.
at the end of the multimodal intervention (3 months)
Rate of compliant General practitioners (GP) associated to the study
Time Frame: at 12 months
at 12 months
Assessment of psychological factors using GDS-4 scale associated with a loss of mobility
Time Frame: baseline, 6 and 12 months
Using a short Geriatric Depression Scale (GDS-4). The GDS may be used with healthy, medically ill and mild to moderately cognitively impaired older adults.
baseline, 6 and 12 months
Assessment of social factors associated with a loss of mobility
Time Frame: baseline
Using the Evaluation of Precarity and Inequalities in Health Examination Centers (EPICES) score which is related to several socioeconomic indicators (occupation, education, and employment status), to health-related behaviors (smoking and health care use), and morbidity (self-perceived health, dental health, obesity, and diabetes).
baseline
Assessment of comorbidities using the index of Charlson
Time Frame: baseline
Using the index of Charlson which included a closed list of 19 diseases, grouped into 4 subgroups different weighting.
baseline
Description of concomitant medications
Time Frame: baseline
List of active drugs and psychotropic
baseline
Type of diagnoses for unknown diseases following the dedicated geriatric consultation.
Time Frame: baseline
Description of pathologies possibly associated with a symptomatic loss of mobility.
baseline
Percentage of diagnoses for unknown diseases following the dedicated geriatric consultation.
Time Frame: baseline
Description of pathologies possibly associated with a symptomatic loss of mobility.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marc BONNEFOY, Pr, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2018

Primary Completion (Actual)

March 1, 2021

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

July 21, 2016

First Submitted That Met QC Criteria

July 27, 2016

First Posted (Estimated)

July 28, 2016

Study Record Updates

Last Update Posted (Estimated)

December 19, 2025

Last Update Submitted That Met QC Criteria

December 13, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 69HCL16_0132

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elderly Patient (>70 Years)

Clinical Trials on PRISME-3P program

Subscribe